Skip to main content
Premium Trial:

Request an Annual Quote

AB Sciex, Premier Biosoft Partner on Lipidomic Software

NEW YORK (GenomeWeb News) – Premier Biosoft today announced a co-marketing and reselling deal with AB Sciex for lipidomic research software.

Under the terms of the deal, AB Sciex, a Danaher company, will co-market and resell Premier's SimLipid, a high-throughput lipid identification software product, for use with AB Sciex's mass spectrometers.

SimLipid profiles lipids in samples by doing a precursor search for mass spec data and provides structural information by matching product ions observed on MS/MS spectra. According to Premier, the software can be used for analyzing both low-resolution and high-resolution data.

"Combining AB Sciex's mass spectrometery data with SimLipid creates an opportunity for researchers to gain access to unparalleled information for lipid characterization," Premier President Kay Brown said in a statement.

Financial and other terms of the deal were not disclosed.

In 2008 Premier and AB Sciex, which at the time was part of Applied Biosystems, collaborated on the development of integrated workflows for glycomics research.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.